Evaluation of Various Static and Dynamic Modeling Methods to Predict Clinical CYP3A Induction Using In Vitro CYP3A4 mRNA Induction DataHeidi J. Einolf, Ping Zhao, Jashvant D. Unadkat et al.|Clinical Pharmacology & Therapeutics|2013Cited by 93
BIOACTIVATION OF THE 3-AMINO-6-CHLOROPYRAZINONE RING IN A THROMBIN INHIBITOR LEADS TO NOVEL DIHYDRO-IMIDAZOLE AND IMIDAZOLIDINE DERIVATIVES: STRUCTURES AND MECHANISM USING 13C-LABELS, MASS SPECTROMETRY, AND NMRRaju Subramanian, Rominder Singh, Charles C. Lin et al.|Drug Metabolism and Disposition|2003Cited by 11
INDUCTION OF CYP1A IN THE BEAGLE DOG BY AN INHIBITOR OF KINASE INSERT DOMAIN-CONTAINING RECEPTOR: DIFFERENTIAL EFFECTS IN VITRO AND IN VIVO ON MRNA AND FUNCTIONAL ACTIVITYChristopher R. Gibson, Thomas H. Rushmore, Charles C. Lin et al.|Drug Metabolism and Disposition|2005Cited by 6
Assessing modeling methods for predicting clinical CYP3A induction: A collaborative effort among academic, government regulatory, and pharmaceutical industry scientistsHeidi J. Einolf, Ping Zhao, Liangfu Chen et al.|Unknown|2013Cited by 0